Metraipolis › archive › dc_02f104460aff

The development and pilot testing of a behavioral activation-based treatment for depressed mood and multiple health behavior change in patients with recent… — Europe PMC PMID:35113860

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/35113860
DOI
10.1371/journal.pone.0261490
License (as archived)
CC0-1.0
Archived
2026-10-31T10:26:46.226Z
SHA-256 of the archived text
79e4cef7847d07c379e70d14595be1d90a15716b8676932ae15cfbefa0eb4ac4
Stable URL of this page
https://metraipolis.com/documento/dc_02f104460aff

How to cite

The development and pilot testing of a behavioral activation-based treatment for depressed mood and multiple health behavior change in patients with recent… — Europe PMC PMID:35113860 — Europe PMC (en), https://europepmc.org/article/MED/35113860 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_02f104460aff (Metraipolis archive dc_02f104460aff, sha256 79e4cef7847d07c379e70d14595be1d90a15716b8676932ae15cfbefa0eb4ac4)
BibTeX
@misc{dc02f104460aff,
  title = {The development and pilot testing of a behavioral activation-based treatment for depressed mood and multiple health behavior change in patients with recent… — Europe PMC PMID:35113860},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/35113860},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_02f104460aff; sha256 79e4cef7847d07c379e70d14595be1d90a15716b8676932ae15cfbefa0eb4ac4},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/35113860. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: Patients with acute coronary syndrome (ACS) with depressed mood demonstrate poor cardiovascular behavioral risk profiles and elevated risk for recurrent ACS and mortality. Behavioral Activation (BA) offers an intervention framework for an integrated treatment targeting both depression and critical health behaviors post-ACS. Behavioral Activation for Health and Depression (BA-HD) was developed and pilot tested in a multiphase iterative process. Methods: First, an initial treatment manual was conceptualized based on the team's prior work, as well as the extant literature. Second, qualitative interviews were conducted with target patients and target providers on the proposed BA-HD treatment rationale, content, and structure. Framework matrix analyses were used to summarize and aggregate responses. Third, an expert panel was convened to elicit additional manual refinements. Finally, patients with post-ACS depression and health behavior non-adherence were recruited to complete an open pilot trial to evaluate acceptability (Client Satisfaction Questionnaire [CSQ], exit interview) and treatment engagement (number of sessions attended; treatment completion was considered completion of 8 out of 10 possible sessions). Results: The initial BA-HD treatment manual expanded an existing treatment manual for post-ACS BA-based mood management and smoking cessation to target four health behaviors relevant to post-ACS patients (e.g., smoking cessation, medication adherence, physical activity, and diet). After the initial conceptualization, ten post-ACS patients and eight cardiac rehabilitation professionals completed qualitative interviews. Patients endorsed bi-directional interactions between mood and health behaviors post-ACS. Both patients and providers expressed general support of the proposed treatment rationale and values-guided, collaborative goal-setting approach. Patients, providers, and experts provided feedback that shaped the iterative manual development. After the BA-HD manual was finalized, eight participants were enrolled in a single-arm pilot trial. The mean CSQ score was 30.57 ± 2.23, indicating high satisfaction. Seven out of eight (88%) completed treatment. Pre- to post treatment improvements in depressed mood and health behaviors were promising. Conclusions: BA-HD treatment is an acceptable approach to target both mood and health behaviors in post-ACS patients with depression. A future larger, controlled trial is needed to evaluate the efficacy of the BA-HD treatment. Trial registration: ClinicalTrials.gov Identifier: NCT04158219.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2022 (prima pubblicazione 2022-02-03).
Identificativi: PMID 35113860 · PMCID PMC8812840 · DOI 10.1371/journal.pone.0261490.
Descrittori MeSH principali: Depression; Health Behavior; Acute Coronary Syndrome.
Pagina: https://europepmc.org/article/MED/35113860 — https://doi.org/10.1371/journal.pone.0261490. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-31T10:07:46.508Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.